QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roy Travis who wrote (337)	8/17/1998 2:12:00 PM
From: Archangel	Read Replies (1) of 1321

Well how do you explain its longevity, then, if it's so overpriced? Or maybe that doesn't make sense. At any rate, QLTIF was able to persuade investors to pop another $15 Mill into the coffers to cover off on product number 2. This company has a lot more possiblity than many others in Vancouver; not only are there a number of possible indications and markets for verteporfin, but QLTIF has the product development infrastructure to realize goals.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next